For the first-line treatment of patients with unresectable advanced or metastatic malignant pleural mesothelioma
Company will invest in capacity increases, technological capabilities and long-term partnerships with key pharmaceutical and biotech companies
lAIH strives to introduce appropriate interventions for nurturing an AMR innovation ecosystem in the country through cohesive efforts across the innovation pyramid
With this additional route of administration, the MMRV Family now joins other routinely recommended vaccines that can be administered intramuscularly
The audit was commenced for newly renovated manufacturing Block 1, Block 2, and Block 3
Jan Aushadhi highlights achievements of women of the country at 34 locations by felicitating all women stakeholders under the scheme
Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event
The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health.
The marketing authorisations for three generic drugs signifying advances in cancer treatment will considerably benefit thousands of patients by improving access, ensuring affordability
At commercial scale, Bluestem's patent pending technologies will reduce carbon emission by an estimated 75% or more and be cost-competitive with petroleum based chemicals
Subscribe To Our Newsletter & Stay Updated
